hotspot -WSS

hotspot

author：explore 2025-10-04 03:59:37 - browse：6

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： AstraZeneca bets AAV gene therapy will still deliver the goods

hotspot

WSS

Drug firms test therapies to halt Alzheimer’s before symptoms arise

How Long Island became the ‘eugenics capital of the world’

Neuroscience startup Neumora files for IPO

FDA panel endorses Alnylam’s heart drug — after picking it apart

Hospitals consider fixing cancer drug shortages on their own

In science, is the line between industry and academia shifting?

hotspot

hotspot

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Private equity could exacerbate cardiology's overuse problem, experts fear

The high cost of giving birth even with insurance

Popular nasal decongestant doesn't actually relieve congestion

Alkermes shareholders re

Why more medical students aren't specializing in primary care

What does generative AI mean for health care? We asked experts

Neuroscience startup Neumora files for IPO

Supreme Court strikes down use of affirmative action

In science, is the line between industry and academia shifting?

Wikipedia

What AAP's gender

Neuroscience startup Neumora files for IPO

NYU Langone launches private ChatGPT for its health care data

Generate Biomedicines machine learning biotech raises $273M

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

FDA panel gives mixed vote on blood pressure devices

knowledge

hotspot

entertainment

focus